Doug Hampton

E-health Sector Soars with 100% Turnover Growth

by

DUBAI, UAE, Jan. 28, 2024 /PRNewswire/ — Estonia, renowned for its cutting-edge healthcare research and development, is set to make a significant mark at Arab Health 2024, showcasing its expertise and collaboration opportunities to the GCC region. Estonia’s Digital Health Triumph Shines at Arab Health 2024: E-health Sector Soars with 100% Turnover Growth (PRNewsfoto/Enterprise Estonia) … Read more

AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc.

by

NEW ORLEANS, Jan. 26, 2024 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of  Ambrx Biopharma, Inc. (NasdaqGS: AMAM) to Johnson & Johnson (NYSE: JNJ).  Under the terms of the proposed transaction, shareholders of Ambrx … Read more

Critical Path Institute ernennt Dr. Klaus Romero zum neuen CEO und befördert Cécile Ollivier zur Vizepräsidentin für globale Angelegenheiten

by

AMSTERDAM, 26. Januar 2024 /PRNewswire/ — Das Critical Path Institute (C-Path) hat Dr. Klaus Romero, M.D., M.S., FCP, zu seinem neuen geschäftsführenden Direktor ernannt und Cécile Ollivier, M.S., von Managing-Direktorin, Europa, zur Vizepräsidentin für globale Angelegenheiten befördert. Klaus Romero, M.D., M.S., FCP, Chief Executive Officer, Critical Path Institute Cécile Ollivier, M.S., Vice President of Global … Read more

New Research Hubs Established in the Greater Boston area in the US and Japan to Strengthen Support for Drug Discovery and Innovation

by

MELVILLE, N.Y., Jan. 25, 2024 /PRNewswire/ — Nikon Instruments Inc. (Nikon) is pleased to announce the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, USA, where it will provide research and development functions as well as drug discovery support development services. Similarly, the Nikon Healthcare R&D Center, a new research and development facility specializing … Read more

Laparoscopic Gynecological Procedures Market Set to Reach $42.3 Billion by 2030 with Robust Technological Innovations and Increasing Demand in Minimally Invasive Surgeries

by

DUBLIN, Jan. 24, 2024 /PRNewswire/ — The “Global Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report by Procedure (Laparoscopic Hysterectomy, Laparoscopic Myomectomy), End-use (ASCs, Hospitals), Region, and Segment Forecasts, 2023-2030” report has been added to  ResearchAndMarkets.com’s offering. The latest insights on the global laparoscopic gynecological procedures market highlight a projected exponential growth, expecting to achieve … Read more

INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness

by

Global landscape analysis identifies strengths and gaps in R&D pipeline to inform international pandemic preparedness efforts ROME and CAMBRIDGE, Mass., Jan. 23, 2024 /PRNewswire/ — The INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating the development of antiviral treatments to help protect the world ahead of future pandemics, today published the first phase … Read more

Gannex’s Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH USA – English APAC – Traditional Chinese

by

Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis –  Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD Activity Score) in 36% of denifanstat-treated patients vs 13% with placebo (p=0.002) ≥2-point reduction … Read more

Antibody Therapeutics Market Size to Grow USD 364180 Million by 2029 at a CAGR of 11%

by

BANGALORE, India, Jan. 21, 2024 /PRNewswire/ — Antibody Based Therapeutics Market is Segmented by Type (Monoclonal Antibodies, Bi-Specific Antibodies Therapy, Antibody-drug Conjugates), by Application (Immune Diseases, Cancer): Global Opportunity Analysis and Industry Forecast, 2023-2029. It is Published in Valuates Reports Under the Category of Pharmaceuticals & Biotech. Antibody Based Therapeutics Market is projected to reach USD … Read more

First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan

by

The Progeria Research Foundation Marks Significant Achievement as Zokinvy™ (lonafarnib) Receives Japanese Approval for the Treatment of Progeria and Processing-Deficient Progeroid Laminopathies PEABODY, Mass., Jan. 20, 2024 /PRNewswire/ — The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of Health, Labor and Welfare (MHLW), for … Read more

Global Vaginal Rejuvenation (Reconstructive, Cosmetic) Research Report 2023-2030

by

DUBLIN, Jan. 19, 2024 /PRNewswire/ — The “Global Vaginal Rejuvenation Market Size, Share & Trend Analysis By Treatment Type (Reconstructive, Cosmetic), Type, Application, Age Category, Region and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering. The global vaginal rejuvenation market size is expected to reach USD 14.34 billion by 2030, registering a CAGR of 22.07% from … Read more